BSEBoard Meeting4d ago · 9 Aug 2026, 06:49 pm
Sudarshan Pharma Industries Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/08/2026 ,inter alia, to consider and approve Unaudited Standalone ....
Sudarshan Pharma Industries Ltd · 543828
✦ AI SummaryResults
Sudarshan Pharma Industries Ltd has informed BSE that the meeting of the Board of Directors is scheduled on 12/08/2026 to consider and approve Unaudited Standalone Financial Results for the quarter ended 30/06/2026.
Analysis Scores
Earnings Impact5/10
Growth Catalyst2/10
Governance Concern1/10
Regulatory Risk1/10
Balance Sheet Risk1/10
Liquidity Impact5/10
Market Sentiment5/10
✦ Ask a Question
Ask anything about this announcement — AI will answer based on the filing content.
Full Announcement
Sudarshan Pharma Industries Ltd - 543828 - Board Meeting Intimation for To Consider And Approve Financial Results For The Quarter Ended 30/June/2026
Attachments (1)
📄pdf
Download →
c1d15c91-e5c3-4c56-9e4c-91ff907f31ae.pdf
View document text
EUDIRXHIII PHIRIIA IIIDU$TRIEX tTD
Head Office : 30'1, Aura Biplex, Premium Retail Premises, 7, S.V. Hoad, Borivali (West), lVlumbai - 400092.
E-mail : compliance@sudarshanpharma.com . Website: www.sudarshanpharma,com
Board Line: +91-22'42221111 14333'1111 142221116 (100line)rQlli1 :151496[/H2008P1C184997
sPrJ-/CS/SE/ 2026-2027 / 41, Date: 9ft August2026
The Listing Department
BSE Limited BSE Scrip Code: 543828
Phiroze ]eejeebhoy Towers, BSE Trading Symbol: SUDARSHAN
Dalal Street, Mumbai - 400 001 ISIN: INE00TV01023
Dear Sir/Madam,
Sub: Meeting of the Board of Directors of the Company scheduled to be held on
Wednesd ay, 12th lune, 2026
pursuant to Regulation}g of SEBI (Listing Obligations and Disclosure Requirements)
Ilegulation s, 20L5, we wish to inJorm you that a meeting of the B<rard of Directors of
the Company is scheduled to be held on Wednesday,1rztl'' August, 2026, inter alia, to
cor-rsider ar-rd ,pp.nrre the Unauclited Stanclalone & Consolidated Financial Results of '
the Cornpany for the quarter ended 30th ]une, 2026-
Further, please note that the Trading Window of the Company shall continue to
remain cLosed until the expiry of 48 hours after the declaration of the financial results
for tI-re quarter encled 30tL June, 2026.
Ilequest you to take tl-re salne o11126t11 record
I lranks & Rcgarrls,
For, Sudarshan Pharma Industries Limited
NTOL
Nirarr Shah
Company Secretary plianc
Regd. Off. : 30'1, Aura Biplex, Above Kalyan Jewellers, $,V. Road, Borivali (West), Mumbai - 400092.